First phase of enrollment of single device for CCM® and ICD therapy completeMarlton, NJ, April 28, 2025 (GLOBE NEWSWIRE) -- ...

RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared ...

Island Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.

J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.

Tresidder said his Melbourne-based firm has “a real focus” on biotech and life sciences. He sketched some of the ways brokers ...

On July 11, 2024, Affluent Medical reached a major milestone with the signature of several agreements with Edwards Lifesciences, a global MedTech player, recognizing the relevance and potential of the ...

The agency suggested that clinical trials in humans may be required for updated Covid shots, raising questions about whether ...

Drone814, a new initiative in Greater Johnstown, will begin testing aerial delivery of defibrillators, EpiPens and other ...

Discover phases of acute ischemic stroke care, from rapid recognition to long-term recovery strategies that neurologists use ...

The first-of-its-kind facility in the region will focus on producing next-generation wound care solutions and surgical ...

Learn how UC Davis’ Aggie Square is solving pressing challenges through collaborative research and cutting-edge technology.